Laboratory Corporation of America Holdings (NYSE: LH) is buying LipoScience Inc. (Nasdaq: LPDX) for about $85.3 million.

LipoScience, headquartered in Raleigh, North Carolina, provides specialized cardiovascular diagnostic laboratory tests based on nuclear magnetic resonance technology. The company provides the LipoProfile test, which is approved by the U.S. Food & Drug Administration, measures the LDL-particle number that provides information to doctors about cardiovascular disease.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.